150 related articles for article (PubMed ID: 9694371)
1. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin.
Nankya-Kitaka MF; Curley GP; Gavigan CS; Bell A; Dalton JP
Parasitol Res; 1998 Jul; 84(7):552-8. PubMed ID: 9694371
[TBL] [Abstract][Full Text] [Related]
2. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.
Skinner-Adams TS; Lowther J; Teuscher F; Stack CM; Grembecka J; Mucha A; Kafarski P; Trenholme KR; Dalton JP; Gardiner DL
J Med Chem; 2007 Nov; 50(24):6024-31. PubMed ID: 17960925
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin.
Gardiner DL; Trenholme KR; Skinner-Adams TS; Stack CM; Dalton JP
J Biol Chem; 2006 Jan; 281(3):1741-5. PubMed ID: 16286469
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a cytosolic aminopeptidase from Encephalitozoon intestinalis.
Millership JJ; Chappell CL; Okhuysen PC; Snowden KF
Parasitology; 2002 Jan; 124(Pt 1):1-7. PubMed ID: 11811798
[TBL] [Abstract][Full Text] [Related]
5. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
Chaudhary M; Singh V; Anvikar AR; Sahi S
Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
[TBL] [Abstract][Full Text] [Related]
6. Modelling of human leucyl aminopeptidases for in silico off target binding analysis of potential Plasmodium falciparum leucine aminopeptidase (PfA-M17) specific inhibitors.
Sahi S; Raj U; Chaudhary M; Nain V
Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(3):191-201. PubMed ID: 25269653
[TBL] [Abstract][Full Text] [Related]
7. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
[TBL] [Abstract][Full Text] [Related]
8. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase.
Taylor A; Peltier CZ; Jahngen EG; Laxman E; Szewczuk Z; Torre FJ
Biochemistry; 1992 Apr; 31(16):4141-50. PubMed ID: 1567860
[TBL] [Abstract][Full Text] [Related]
9. Chemical target validation studies of aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phosphonopeptide inhibitors.
Cunningham E; Drag M; Kafarski P; Bell A
Antimicrob Agents Chemother; 2008 Sep; 52(9):3221-8. PubMed ID: 18458130
[TBL] [Abstract][Full Text] [Related]
10. Purification of a leucine aminopeptidase from Eimeria falciformis.
Kaga MM; Laurent F; Doh A; Luffau G; Yvoré P; Péry P
Vet Res; 1998; 29(1):107-11. PubMed ID: 9559525
[TBL] [Abstract][Full Text] [Related]
11. Structure- and function-based design of Plasmodium-selective proteasome inhibitors.
Li H; O'Donoghue AJ; van der Linden WA; Xie SC; Yoo E; Foe IT; Tilley L; Craik CS; da Fonseca PC; Bogyo M
Nature; 2016 Feb; 530(7589):233-6. PubMed ID: 26863983
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of PfA-M1, over PfA-M17, by an amino-benzosuberone derivative blocks malaria parasites development in vitro and in vivo.
Bounaadja L; Schmitt M; Albrecht S; Mouray E; Tarnus C; Florent I
Malar J; 2017 Sep; 16(1):382. PubMed ID: 28934959
[TBL] [Abstract][Full Text] [Related]
13. Aminopeptidases from Plasmodium falciparum, Plasmodium chabaudi chabaudi and Plasmodium berghei.
Curley GP; O'Donovan SM; McNally J; Mullally M; O'Hara H; Troy A; O'Callaghan SA; Dalton JP
J Eukaryot Microbiol; 1994; 41(2):119-23. PubMed ID: 8167617
[TBL] [Abstract][Full Text] [Related]
14. Molecular Characterization of Babesia bovis M17 Leucine Aminopeptidase and Inhibition of Babesia Growth by Bestatin.
Aboge GO; Cao S; Terkawi MA; Masatani T; Goo Y; AbouLaila M; Nishikawa Y; Igarashi I; Suzuki H; Xuan X
J Parasitol; 2015 Oct; 101(5):536-41. PubMed ID: 26057618
[TBL] [Abstract][Full Text] [Related]
15. The effect of nitric oxide on the growth of Plasmodium falciparum, P. chabaudi and P. berghei in vitro.
Balmer P; Phillips HM; Maestre AE; McMonagle FA; Phillips RS
Parasite Immunol; 2000 Feb; 22(2):97-106. PubMed ID: 10652122
[TBL] [Abstract][Full Text] [Related]
16. Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling.
Gavigan CS; Machado SG; Dalton JP; Bell A
Antimicrob Agents Chemother; 2001 Nov; 45(11):3175-81. PubMed ID: 11600374
[TBL] [Abstract][Full Text] [Related]
17. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
Li X; Chen H; Jeong JJ; Chishti AH
Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361
[TBL] [Abstract][Full Text] [Related]
18. Mapping the Pathway and Dynamics of Bestatin Inhibition of the Plasmodium falciparum M1 Aminopeptidase PfA-M1.
Yang W; Riley BT; Lei X; Porebski BT; Kass I; Buckle AM; McGowan S
ChemMedChem; 2018 Dec; 13(23):2504-2513. PubMed ID: 30318749
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development.
Stack CM; Lowther J; Cunningham E; Donnelly S; Gardiner DL; Trenholme KR; Skinner-Adams TS; Teuscher F; Grembecka J; Mucha A; Kafarski P; Lua L; Bell A; Dalton JP
J Biol Chem; 2007 Jan; 282(3):2069-80. PubMed ID: 17107951
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials.
Skinner-Adams TS; Stack CM; Trenholme KR; Brown CL; Grembecka J; Lowther J; Mucha A; Drag M; Kafarski P; McGowan S; Whisstock JC; Gardiner DL; Dalton JP
Trends Biochem Sci; 2010 Jan; 35(1):53-61. PubMed ID: 19796954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
